Tanzania’s Ministry of Health has issued a directive to implement a national strategy that expands local pharmaceutical and health product manufacturing. The government aims to reduce import dependency, enhance supply security, and expedite investor facilitation through new coordination structures.
The Ministry has outlined a comprehensive framework to develop domestic production capacity for medicines, medical devices, reagents, and other health products. Pharmaceutical imports reached USD 329.9 million in 2021, USD 340.4 million in 2022, USD 286.2 million in 2023, USD 295.3 million in 2024, and are projected at USD 269.9 million in the year ending September 2025, according to the latest Monthly Economic Review by the Bank of Tanzania.
The government aims to substitute part of this demand through local manufacturing and improve investment conditions for private-sector participation. The strategy implements policy priorities under the Ilani ya Chama Cha Mapinduzi 2025–2030 and the directives of the Sixth-Phase Government. The Minister of Health Mohamed Mchengerwa instructed the Ministry’s Permanent Secretary to form a task force within seven days to coordinate and accelerate implementation. He also directed the preparation of a complete list within 15 days of all investors who have expressed interest in pharmaceutical manufacturing since 2015, including their progress, constraints, resource requirements, financial capacity, and reasons for delays.
Read more at: https://www.tanzaniainvest.com/industry/pharmaceutical-manufacturing-directive
